Indegene Ltd (INDGN)
🎯 Key Takeaways
- Revenue grew 5.9% QoQ to ₹1,063 in Q1FY27.
- Market Cap
- ₹14,568
- P/E Ratio
- 36.2
- P/B Ratio
- 4.64
- ROE
- 12.8%
- ROCE
- 17.4%
- Debt/Equity
- 0.00
- Div Yield
- 0.37%
- Promoter
- 0.0%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 804 | 942 | 1,003 | 1,063 |
| Operating Profit | 117 | 120 | 122 | 130 |
| OPM % | 14.6% | 12.7% | 12.1% | 12.2% |
| Net Profit | 102 | 103 | 80 | 116 |
| EPS | ₹4.26 | ₹4.29 | ₹3.32 | ₹4.84 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 48 | 48 | 48 | 48 |
| Reserves | 2,568 | 2,312 | 3,090 | 2,818 |
| Borrowings | 102 | 88 | 0 | 122 |
| Total Liabilities | 3,326 | 3,024 | 4,620 | 3,576 |
| Fixed Assets | 135 | 111 | 1,812 | 161 |
| Investments | 1,290 | 917 | 1,100 | 778 |
| Total Assets | 3,326 | 3,024 | 4,620 | 3,576 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +651 |
| Investing | -512 |
| Financing | -83 |
| Net Cash Flow | +56 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 0.0% | 0.0% | 0.0% | 0.0% |
| FII | 11.3% | 11.5% | 10.3% | 9.9% |
| DII | 7.0% | 8.1% | 8.3% | 8.7% |
| Public | 13.3% | 12.4% | 12.6% | 12.5% |
| # Shareholders | 1,51,809 | 1,47,182 | 1,42,119 | 1,38,533 |
⚖️ Peer Comparison — Healthcare
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.17 L Cr | 56.0 | 22.1% | — | 0.60 |
| MANIPALHOS | 98,509 | — | — | — | 1.25 |
| MAXHEALTH | 95,762 | 65.6 | 14.4% | — | 0.27 |
| ASTERDM | 64,094 | 119.0 | 12.9% | — | 0.17 |
| FORTIS | 61,831 | 59.0 | 13.3% | — | 0.29 |
| MEDANTA | 38,059 | 68.4 | 21.9% | — | 0.10 |
| NH | 36,850 | 44.9 | 13.7% | — | 1.07 |
| LALPATHLAB | 32,792 | 47.2 | 29.6% | — | 0.00 |
| KIMS | 32,345 | 151.0 | 9.7% | — | 1.44 |
| POLYMED | 16,977 | 53.9 | 15.1% | — | 0.06 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🔴 Announcement2026-09-30Indegene Limited announced its Q2 FY27 earnings call scheduled for 30 October 2026 at 8:00 AM IST, inviting investors to hear from Chairman and CEO Ma…
- 🟡 Board Meeting2026-09-30Indegene Ltd announced a board meeting on 29 October 2026 to approve unaudited financial results for the quarter and half year ended 30 September 2026…
- Announcement2026-09-28Indegene Ltd announced the closure of its trading window effective October 1, 2026, due to the upcoming release of quarterly and half-year financial r…
- 🔴 Announcement2026-09-23Indegene announced its Digital Summit 2026, themed 'From Promise to Performance: Operationalizing AI for Enterprise Outcomes,' highlighting AI's role …
- 🔴 Announcement2026-09-10Indegene announced the merger of its German subsidiaries Indegene Healthcare Germany GmbH and Trilogy Writing & Consulting GmbH, effective September 9…
- 🔴 Announcement2026-09-08Indegene Ltd announced its investor and analyst meeting schedule on September 8, 2026, listing a one-on-one session with Premji Invest on September 11…
- 🔴 Financial Results2026-08-31Indegene disclosed that a U.S. District Court preliminarily approved its subsidiary's class-action settlement on 27 August 2026, with final approval s…
- Announcement2026-08-19Indegene Limited announced its investor and analyst meeting schedule for August 24-25, 2026, conducted virtually and in person in Bengaluru, with no p…
- 🔴 Financial Results2026-08-19Indegene Limited disclosed that its US subsidiary Indegene Inc. has reached final settlement terms for a class-action TCPA lawsuit involving approxima…
- 🟡 Board Meeting2026-08-17Indegene Limited announced the results of its 28th Annual General Meeting held on August 13, 2026, where all proposed resolutions were passed with req…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when INDGN files new disclosures
Track INDGN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track INDGN — FreeFree account · 2 AI queries/day